Product Highlight - Comirnaty

Active ingredient: Raxtozinameran

Indications: Active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals ≥12 yr & childn 5-11 yr.

Dosage & Administration: IM Individual ≥12 yr, childn 5-11 yr (ie, 5 to <12 yr) 0.3 mL as a single dose regardless of prior COVID-19 vaccination status. Individual who has previously been vaccinated w/ a COVID-19 vaccine Administer at least 3 mth after the most recent dose of a COVID-19 vaccine. Severely immunocompromised aged ≥12 yr & ≥5 yr Administer additional doses in accordance w/ national recommendations.